Loading the security page…
A security analysis is not yet prepared for this market.
Based on the last 12 months of reports, through 30 June 2026
The sector median covers every company in the sector on the US market, loss-making ones included.
Acumen Pharmaceuticals, Inc. (ABOS) is a company in the Health care sector; its shares trade on Nasdaq.
The price of Acumen Pharmaceuticals, Inc. (ABOS) on November 12, 2026 is 0.2183 $, −5.09 % on the day. Market capitalization is 16.90 million $, rank 117 among 134 stocks of the same industry with a known capitalization.
Acumen Pharmaceuticals, Inc. trades on Nasdaq under the ticker ABOS. The company belongs to the Health care sector. The trading history on this page starts on 1 July 2021.
The company reported a loss over the last four quarters, so a price-to-earnings ratio is not calculated. Price to book is 0.3, below the sector median of 2.4. Calculated from reports for the period ending 30 June 2026.
ABOS has a return on equity of −183.44%, below the sector median of −40.58%. Return on assets is −90.55%, below the sector median of −30.08%.